Подписаться
John Varigos
John Varigos
Department of Epidemiology and Preventive Medicine, Monash University
Подтвержден адрес электронной почты в домене monash.edu
Название
Процитировано
Процитировано
Год
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf, S Hawken, S Ôunpuu, T Dans, A Avezum, F Lanas, M McQueen, ...
The lancet 364 (9438), 937-952, 2004
172802004
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
11962017
Cholesterol lowering in intermediate-risk persons without cardiovascular disease
S Yusuf, J Bosch, G Dagenais, J Zhu, D Xavier, L Liu, P Pais, ...
New England Journal of Medicine 374 (21), 2021-2031, 2016
10182016
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
9392018
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled …
PM Ridker, JG MacFadyen, BM Everett, P Libby, T Thuren, RJ Glynn, ...
The Lancet 391 (10118), 319-328, 2018
8162018
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
EM Lonn, J Bosch, P López-Jaramillo, J Zhu, L Liu, P Pais, R Diaz, ...
New England Journal of Medicine 374 (21), 2009-2020, 2016
7942016
Blood-pressure and cholesterol lowering in persons without cardiovascular disease
S Yusuf, E Lonn, P Pais, J Bosch, P Lopez-Jaramillo, J Zhu, D Xavier, ...
New England Journal of Medicine 374 (21), 2032-2043, 2016
4872016
Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation
S Yusuf, M Flather, J Pogue, D Hunt, J Varigos, L Piegas, A Avezum, ...
The Lancet 352 (9127), 507-514, 1998
4851998
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ...
The Lancet 391 (10117), 205-218, 2018
4052018
On behalf of the INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case …
S Yusuf, S Hawken, S Ôunpuu, T Dans, A Avezum, F Lanas, M McQueen, ...
Lancet 364 (9438), 937, 2004
2432004
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–10